Navigation Links
U.S. EPA Approves Registration of Antimicrobial Copper Alloys
Date:3/25/2008

Copper, brass and bronze kill pathogens - including 'superbug'

MRSA-responsible for hospital- and community-acquired infections

NEW YORK, March 25 /PRNewswire/ -- The U.S. Environmental Protection Agency (EPA) has approved the registration of antimicrobial copper alloys, with public health claims. These public health claims acknowledge that copper, brass and bronze are capable of killing harmful, potentially deadly bacteria. Copper is the first solid surface material to receive this type of EPA registration, which is supported by extensive antimicrobial efficacy testing.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080325/NYTU054 )

The EPA registration is based on independent laboratory testing using EPA-prescribed protocols that demonstrate the metals' ability to kill specific disease-causing bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA). MRSA is one of the most virulent strains of antibiotic-resistant bacteria and a common cause of hospital- and community-acquired infections.

Testing under EPA-approved protocols demonstrates that copper, brasses and bronzes are effective against a number of disease-causing bacteria. For example, one study shows that on copper alloy surfaces, greater than 99.9% of MRSA "superbugs" are killed within two hours at room temperature.

The following statements are included in the registration: "When cleaned regularly, antimicrobial copper alloys surfaces kill greater than 99.9% of (specific) bacteria within two hours, and continue to kill more than 99% of (these) bacteria even after repeated contamination," and, "The use of a copper alloy surface is a supplement to and not a substitute for standard infection control practices; users must continue to follow all current infection control practices, including those practices related to cleaning and disinfection of environmental surfaces. The copper alloy surface material has been shown to reduce microbial contamination, but it does not necessarily prevent cross contamination."

Widely publicized statistics from the Centers for Disease Control and Prevention (CDC) estimate infections acquired in U.S. hospitals affect two million individuals every year and result in nearly 100,000 deaths annually. The use of copper alloys for frequently touched surfaces, as a supplement to existing CDC-prescribed hand-washing and disinfection regimens, has far-reaching implications. Potential uses, that include door and furniture hardware, bed rails, intravenous (IV) stands, dispensers, faucets, sinks and work stations, can help reduce the amount of disease-causing bacteria in patient rooms.

Unlike coatings or other materials treatments, the antibacterial efficacy of copper metals won't wear away: they can offer solid, long-term protection. Discussions are ongoing with major hospital equipment manufacturers about the development of appropriate copper-based products. For additional information about antimicrobial copper, please visit http://www.copper.org.

TO RECEIVE B-ROLL BY SATELLITE C-BAND

TUESDAY, MARCH 25, 2008 2:00-2:15 PM EDT (11:00-11:15 AM PDT)

G-25(c); TRANSPONDER-23 D/L 4160

(V), Audio 6.2/6.8

The Copper Development Association is the information, education, market and technical development arm of the copper, brass and bronze industries in the USA. CDA is a member of the International Copper Association, LTD. network.


'/>"/>
SOURCE The Copper Development Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Arizona Senate Approves Smoking Cessation Treatments for State Medicaid Beneficiaries
2. CMS Approves Home Sleep Testing for Diagnosis of OSA; AASM Experts Available for Comment
3. FDA Approves Abbotts FreeStyle Navigator(R) Continuous Glucose Monitoring System
4. FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting
5. FDA Approves Luvox(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
6. FDA Approves NEXIUM(R) for the Treatment of Short-Term GERD in Children 1 to 11 Years Old
7. U.S. Court Approves AK Steels VEBA Health Care Settlement With Middletown Works Retirees
8. Securian Board Approves 8 Officer Promotions
9. MGT Capital Investments, Inc. Approves Share Buyback Program
10. Kaiser Permanente Approves $29 Million in Community Benefit Grants
11. Otter Tail Corporation Reports Record Revenues and Net Income From Continuing Operations for 2007; Earnings Per Share of $1.78; Board Approves Dividend Increase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and earnest ... for each of his children. “The Angel” is the creation of published author, Marjorie ... York City, and impassioned writer. , When asked of her new book, Marjorie says, ...
(Date:1/20/2017)... ... , ... “I Forgive You”: a fine examination of how God handles sin, including how ... published author, Stephen Miller, who, for over ten long years has been waiting to release ... Trinidad and Tobago, he has been serving the Lord for over twenty years, and he ...
(Date:1/20/2017)... ... ... in Suffolk”: a story of love, secrets, and mystery. “Christmas in Suffolk” is ... works in a daycare and looks for inspiration in the local coffee shop as ... Seymour’s new book is an adventure of love and secrets. , After ...
(Date:1/20/2017)... , ... January 20, 2017 , ... “Knowledge is God’s ... guided by faith. “Knowledge is God’s Lighthouse” is the creation of published author, Gene ... novels, and poetry collections. , “I have been writing since high school and ...
(Date:1/20/2017)... , ... January 20, 2017 , ... “God's Miracle Man: ... All Odds” is the creation of published author, Keith C. A. Tucker, son of ... Christian Fellowship World Outreach pastured by Reverend Mark Hardy , “While sitting up in ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... YORK , January 19, 2017 According ... market for cryotherapy is set to witness a CAGR of 6.5% ... North America will continue to be the leading market ... ... Suppliers are emphasizing on ensuring affordable and adequate supply of ...
(Date:1/19/2017)... RATON, Fla. , Jan. 19, 2017 /PRNewswire/ ... a medical device company specializing in the treatment ... such as keloids, with superficial radiation therapy, today ... and full year 2016 financial results on Thursday, February ... The Company will hold a conference call with ...
(Date:1/19/2017)... 2017 Pfizer joins Astex, ... Therapeutics Consortium   Major research investment ...   The Milner Therapeutics Institute ... as a partner to the Milner Therapeutics Consortium. Pfizer ... efficient transfer of materials between industry and academia and ...
Breaking Medicine Technology: